Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linlin Yang

Showing results (461-470 of 468) with videos related to

Pageof 47
Sort By:
You have reached the last page of results.This site can display upto 468 results.
The Journal of Allergy and Clinical Immunology|August 8, 2017
Plasma cell deficiency in human subjects with heterozygous mutations in Sec61 translocon alpha 1 subunit (SEC61A1)Desirée Schubert, Marie-Christine Klein, Sarah Hassdenteufel, et al.
Biorxiv : the Preprint Server for Biology|November 25, 2020
An Engineered Antibody with Broad Protective Efficacy in Murine Models of SARS and COVID-19C Garrett Rappazzo, Longping V Tse, Chengzi I Kaku, et al.
Science Immunology|June 17, 2018
ZNF341 controls STAT3 expression and thereby immunocompetenceStefanie Frey-Jakobs, Julia M Hartberger, Manfred Fliegauf, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
Rapid isolation of potent SARS-CoV-2 neutralizing antibodies and protection in a small animal modelThomas F Rogers, Fangzhu Zhao, Deli Huang, et al.
Science (New York, N.Y.)|January 26, 2021
Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibodyC Garrett Rappazzo, Longping V Tse, Chengzi I Kaku, et al.
Nature|May 18, 2017
Structure of the full-length glucagon class B G-protein-coupled receptorHaonan Zhang, Anna Qiao, Dehua Yang, et al.
Nature Communications|June 4, 2021
Drug repurposing screens identify chemical entities for the development of COVID-19 interventionsMalina A Bakowski, Nathan Beutler, Karen C Wolff, et al.
Science (New York, N.Y.)|June 17, 2020
Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal modelThomas F Rogers, Fangzhu Zhao, Deli Huang, et al.
Pageof 47

Showing results (461-470 of 468) with videos related to

Sort By:
Pageof 47
You have reached the last page of results.This site can display upto 468 results.
The Journal of Allergy and Clinical Immunology|August 8, 2017
Plasma cell deficiency in human subjects with heterozygous mutations in Sec61 translocon alpha 1 subunit (SEC61A1)Desirée Schubert, Marie-Christine Klein, Sarah Hassdenteufel, et al.
Biorxiv : the Preprint Server for Biology|November 25, 2020
An Engineered Antibody with Broad Protective Efficacy in Murine Models of SARS and COVID-19C Garrett Rappazzo, Longping V Tse, Chengzi I Kaku, et al.
Science Immunology|June 17, 2018
ZNF341 controls STAT3 expression and thereby immunocompetenceStefanie Frey-Jakobs, Julia M Hartberger, Manfred Fliegauf, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
Rapid isolation of potent SARS-CoV-2 neutralizing antibodies and protection in a small animal modelThomas F Rogers, Fangzhu Zhao, Deli Huang, et al.
Science (New York, N.Y.)|January 26, 2021
Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibodyC Garrett Rappazzo, Longping V Tse, Chengzi I Kaku, et al.
Nature|May 18, 2017
Structure of the full-length glucagon class B G-protein-coupled receptorHaonan Zhang, Anna Qiao, Dehua Yang, et al.
Nature Communications|June 4, 2021
Drug repurposing screens identify chemical entities for the development of COVID-19 interventionsMalina A Bakowski, Nathan Beutler, Karen C Wolff, et al.
Science (New York, N.Y.)|June 17, 2020
Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal modelThomas F Rogers, Fangzhu Zhao, Deli Huang, et al.
Pageof 47